Chronic Pain Clinical Trial
— PREDIBACKOfficial title:
A Multicenter Prospective Study on Failed Back Surgery Syndrome Pathway Optimization: A Focus on Patient Identification, Chronicization Factors and Outcome Predictors
Verified date | July 2019 |
Source | Poitiers University Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This pilot study is part of a global project that aims to better define and understand
features of FBSS/POPS "post-operative persistent syndrome patients (shortened as "FBSS" in
the following project). FBSS is the acronym for Failed Back Surgery Syndrome, which has been
defined as a chronic condition resulting from spinal interventions. Despite anatomically
successful spine surgery, a significant proportion of patients is experiencing chronic
refractory back and leg pain. In a recent multicentre study conducted on more than 100
refractory FBSS patients, (ESTIMET Study), the mean delay between pain occurrence and FBSS
diagnosis was 5 years. Therefore, FBSS pattern and potential responder stratification might
guide us to eventually develop a decision tool for identifying FBSS patients. Easing and
helping diagnosis of FBSS should improve referral yield to specialists and accelerate patient
flow through the care pathway. Hence, FBSS patients, who usually present a long standing
history of pain, would have access to "appropriate" therapies earlier. This could lead to
better outcomes. The aim of this multicentre, prospective study is to collect specific data
that are not collected in routine in order to better define and understand the potential FBSS
population and to accelerate the diagnostic and optimize the choice of appropriate treatment.
A multidisciplinary approach through a pain management clinical network, as it has been
structured in Poitiers, will ensure that an exhaustive characterization of FBSS patients and
their care pathway will be collected. In addition, since the cooperation between orthopaedic
and neuro spine surgeons is not a common relationship found all over Europe (as it is
observed in Poitiers), this study also aims to better understand the development of
interactions between physicians/professionals and the substantial advantage which would
result from bridging this gap. The N3MT (NeuroMapping Tools) software developed in Poitiers
to collect data and assess objectively pain surface and intensity changes, before/after any
treatment, with quantitative measurements, will be used as the central key of this project.
Status | Completed |
Enrollment | 200 |
Est. completion date | May 31, 2019 |
Est. primary completion date | May 16, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 80 Years |
Eligibility |
Inclusion Criteria: - Patient has signed and dated the Informed Consent Form. - Patient is = 18 years of age at time of "Informed Consent Form" signature. - Patient had most recent back surgery more than 6 months ago. - Patient has developed post-operative Chronic Back with or without Leg Pain (potential FBSS). - Patient has persistent back pain for more than 6 months. - Average low back or leg pain is = 4 as assessed by the baseline NPRS. Exclusion Criteria: - Patient has already a confirmed FBSS diagnosis. - Patient is or has been treated with SCS, subcutaneous or peripheral nerve stimulation, an intrathecal drug delivery system. - Investigator suspects substance abuse that might confound the study results. - Patient has a life expectancy of less than 12 months beyond study enrollment. - Patient is less than 18 years of age. - Patient is pregnant or planning to become pregnant during the course of the study. - Patient is unable to undergo study assessments or complete questionnaires independently (e.g., is illiterate). - Patient is a member of a vulnerable population. |
Country | Name | City | State |
---|---|---|---|
France | Poitiers Hospital University | Poitiers |
Lead Sponsor | Collaborator |
---|---|
Poitiers University Hospital |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Incidence of clinical diagnosis of FBSS | Incidence of clinical diagnosis of FBSS in the broad population of post-surgical pain syndrome, identified by multidisciplinary team of independent experts (1 pain physician, 1 neurosurgeon and 1 psychiatric), with morphological and clinical characterization of the syndrome. | 12 month-follow up visit | |
Secondary | Pain intensity (NRPS) | Reduction of the NRPS score measuring pain intensity: Global pain, Back pain and Leg pain. Proportion of patients with NRPS score < 4. Proportion of patients obtaining a reduction = 25%, 50% and 75%: Global pain, Back pain and Leg pain NRPS. |
Initial visit and 3 month, 6 month, 9 month and 12 month-follow up Visits | |
Secondary | Pain surface and intensity (Mapping Tool) | Reduction of the Global Pain Surface measured on the NeuroPain't module of the software, during treatment, before/after a therapeutic strategy is used. Reduction of pain intensities associated with the quantitative surface measurements. Reduction of the mechanical/neuropathic component of objective pain. |
Initial visit and 3 month, 6 month, 9 month and 12 month-follow up Visits | |
Secondary | Functional capacity (ODI) | Initial visit and 3 month, 6 month, 9 month and 12 month-follow up Visits | ||
Secondary | Quality of life (EQ5D) | Initial visit and 3 month, 6 month, 9 month and 12 month-follow up Visits | ||
Secondary | Psychological State (HADS) | Initial visit and 3 month, 6 month, 9 month and 12 month-follow up Visits | ||
Secondary | Pain Catastrophizing Scale (PCS CF) | Initial visit and 3 month, 6 month, 9 month and 12 month-follow up Visits | ||
Secondary | Adverse Events/ Serious Adverse Events | Initial visit and 3 month, 6 month, 9 month and 12 month-follow up Visits |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01659073 -
Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation
|
N/A | |
Recruiting |
NCT05914311 -
Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration
|
N/A | |
Recruiting |
NCT05422456 -
The Turkish Version of Functional Disability Inventory
|
||
Enrolling by invitation |
NCT05422443 -
The Turkish Version of Pain Coping Questionnaire
|
||
Completed |
NCT05057988 -
Virtual Empowered Relief for Chronic Pain
|
N/A | |
Completed |
NCT04385030 -
Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury
|
N/A | |
Recruiting |
NCT06206252 -
Can Medical Cannabis Affect Opioid Use?
|
||
Completed |
NCT05103319 -
Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
|
||
Completed |
NCT03687762 -
Back on Track to Healthy Living Study
|
N/A | |
Completed |
NCT04171336 -
Animal-assisted Therapy for Children and Adolescents With Chronic Pain
|
N/A | |
Completed |
NCT03179475 -
Targin® for Chronic Pain Management in Patients With Spinal Cord Injury
|
Phase 4 | |
Completed |
NCT03418129 -
Neuromodulatory Treatments for Pain Management in TBI
|
N/A | |
Completed |
NCT03268551 -
MEMO-Medical Marijuana and Opioids Study
|
||
Recruiting |
NCT06204627 -
TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain
|
N/A | |
Recruiting |
NCT06060028 -
The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain
|
N/A | |
Completed |
NCT05496205 -
A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00983385 -
Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics
|
Phase 3 | |
Recruiting |
NCT05118204 -
Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization
|
Phase 4 | |
Terminated |
NCT03538444 -
Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder
|
N/A | |
Not yet recruiting |
NCT05812703 -
Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain
|